Medicare open enrollment provides opportunities to improve your insurance coverage. Open enrollment is fast approaching.
Oncotype DX AR-V7 Test Approved for Coverage by Medicare
Epic Sciences and Genomic Health, Inc. today announced that a local Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final local coverage determination (LCD) for the Oncotype DX® AR-V7 Nucleus Detect™ test.